Quick Answer: No, commercially available GLP-1 patches have not been proven effective and lack FDA approval for weight loss or diabetes management
She now prefers plain sweet potato or salmon
This would make it the third major incretin-based obesity drug to reach the market, following semaglutide (Wegovy) and tirzepatide (Zepbound), but the first to use the full triple-agonist mechanism
This can save 2 to 4 months
Primary Functions of GLP-2 Intestinal Growth and Repair Promotes growth of the intestinal lining (mucosa) Increases the height of intestinal villi (finger-like projections that absorb nutrients) Stimulates crypt cell proliferation Enhances overall intestinal surface area Nutrient Absorption Improves the absorption of nutrients from food Increases blood flow to the intestines Enhances nutrient uptake capacity Supports optimal digestive function Gut Barrier Function Strengthens the intestinal barrier Reduces intestinal permeability (leaky gut) Protects against harmful substances entering the bloodstream Maintains gut integrity Anti-Inflammatory Effects Reduces inflammation in the intestinal tract Promotes healing of damaged tissue Supports immune function in the gut May help with inflammatory bowel conditions Slows Gastric Emptying Like GLP-1, GLP-2 also slows stomach emptying Allows more time for nutrient absorption Contributes to feelings of satiety Why People Use GLP-2 Short Bowel Syndrome: GLP-2 analogs (like teduglutide) are FDA-approved for treating short bowel syndrome, a condition where part of the intestine has been removed
But right now, patients should understand the difference between exciting trial news and treatment that is already part of standard care
